• About Us
  • Success Stories
  • Articles
  • FAQ
  • Contact Us
Accell Clinical Research
  • Our Services
    • Clinical Trial Management
    • Functional Outsourcing
    • Strategic Guidance & Trial Set-up
  • Our Locations
  • Rescue Studies
  • Accell Oncology
Select Page

Outperforming in an Onco-Hematology Clinical Trial

by bd@accellclinical.com | Feb 19, 2018

Meticulously selected by Accell, Russian sites twice outperformed enrollment in Western European sites and 6 times in US sites.

Inventive operational strategy for a cardiology rescue study

by bd@accellclinical.com | Dec 13, 2017

Phase III clinical trial in cardiology for a global top-10 pharmaceutical company. Accell recruited 130% of promised patients before the deadline for patient recruitment.

Oncology Phase III Rescue Study

by bd@accellclinical.com | Dec 13, 2017

After 16 months of slow recruitment, Sponsor addressed Accell to add an emergency country to rescue the study. Accell recruited 21.6% of total patients in just 6 months.

Top Recruiters in Ulcerative Colitis Phase III Study

by bd@accellclinical.com | Dec 13, 2017

Accell recruited 84% of total patients, with only 65% of a total number of study sites, and made sure the Sponsor ended recruitment earlier than planned and faster entered the market.

Recent Posts

  • Hello world!

Recent Comments

    Archives

    • December 2017

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Company News

    February 6, 2023

    European Union Clinical Trial Regulation 2023 update

    The EU has finally implemented its single portal submission regulation for clinical trial authorization. Accell is ready for the change. Are you?

    November 5, 2022

    Accell attended CPHI Frankfurt 2022

    CPHI Frankfurt was a definitive go-to event that united over 100,000 pharmaceutical professionals and 1,000 exhibitors presenting their pharmaceutical products, solutions, and services across the full supply chain.

    Events

    CPHI Frankfurt 2022

    Meet Accell’s team at the biggest pharma industry event of 2022 – CPHI Frankfurt, held at Messe Frankfurt, Frankfurt, Germany on November 1-3, 2022.

    2022 ASCO Annual Meeting

    Learn numerous advantages of running an oncology clinical trial in Eastern Europe from Accell’s team, your trusted CRO partner.

    Immuno-Oncology 360°

    On February 26-28, 2020 Natalia Nayanova, Accell’s Founder and Managing Member, attended the annual conference “Immuno-Oncology 360°” held in Crowne Plaza Times Square in New York City.

    Accell Clinical Research, LLC is an International Contract Research Organization (CRO) supporting innovation with superior clinical trial services in Europe and the Eurasian Economic Union for over a decade.
    • Facebook
    • 
    • Careers
    • Privacy Notice
    • Site Map
    X

    We are here when you need us.
    Get in touch and let’s start something great together.



      Sign Up for Accell’s Newsletter